|
PHiD-CV group
|
Control group
|
---|
Antigen (cut-off)
|
N
|
% (95% CI)
|
GMC (95% CI)
|
N
|
% (95% CI)
|
GMC (95% CI)
|
---|
Diphtheria toxoid (0.1 IU/mL)
|
110
|
100 (96.7-100)
|
4.103 (3.527-4.773)
|
112
|
100 (96.8-100)
|
3.130 (2.731-3.588)
|
Tetanus toxoid (0.1 IU/mL)
|
110
|
100 (96.7-100)
|
6.484 (5.511-7.628)
|
112
|
100 (96.8-100)
|
4.588 (3.880-5.426)
|
Bordetella pertussis (15 EL.U/mL)
|
110
|
100 (96.7-100)
|
111.9 (102.0-122.7)
|
111
|
100 (96.7-100)
|
124.9 (111.7-139.7)
|
HBs (10 mIU/mL)
|
91
|
97.8 (92.3-99.7)
|
1835.1 (1384.0-2433.2)
|
96
|
100 (96.2-100)
|
1485.5 (1198.7-1840.9)
|
PRP (0.15 μg/mL)
|
110
|
100 (96.7-100)
|
18.461 (14.256-23.907)
|
112
|
99.1 (95.1-100)
|
10.137 (7.515-13.673)
|
-
NOTE. GMC, geometric mean antibody concentration; HBs, hepatitis B surface antigen; PRP, Haemophilus influenzae type b polyribosylribitol phosphate; N, number of subjects with available results